Authors: LECA FR MARCHISETLECA D GALEANI A NOBLE A CATALIN J

Citation: Fr. Leca et al., PHARMACOKINETIC-PHARMACODYNAMIC RELATIONSHIPS BETWEEN PIRARUBICIN EXPOSURE AND HEMATOTOXICITY - CLINICAL-APPLICATION USING ONLY ONE BLOOD-SAMPLE, Anti-cancer drugs, 9(6), 1998, pp. 503-509

Authors: MARCHISETLECA D LECA FR GALEANI A NOBLE A ILIADIS A

Citation: D. Marchisetleca et al., A LIMITED SAMPLING STRATEGY FOR THE STUDY OF PIRARUBICIN PHARMACOKINETICS IN HUMANS, Cancer chemotherapy and pharmacology, 36(3), 1995, pp. 233-238

Authors: MARCHISETLECA D LECA FR GALEANI A NOBLE A CATALIN J

Citation: D. Marchisetleca et al., PHARMACOKINETICS AND METABOLISM OF PIRARUBICIN IN HUMANS - CORRELATION WITH PHARMACODYNAMICS, Cancer chemotherapy and pharmacology, 36(3), 1995, pp. 239-243

Authors: MARCHISETLECA D LECA FR

Citation: D. Marchisetleca et Fr. Leca, HIGHLY SENSITIVE METHOD FOR THE DETERMINATION OF A NEW ANTHRACYCLINE - PIRARUBICIN, Chromatographia, 35(7-8), 1993, pp. 435-438